José Inciarte-Mundo Selected Research

Palindromic rheumatism

12/2021	Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status.
1/2017	Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis.
8/2014	Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? a clinical and ultrasonographic study according to anticitrullinated protein antibody status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Inciarte-Mundo Research Topics

Disease

13	Rheumatoid Arthritis 08/2022 - 12/2015
5	Psoriatic Arthritis 12/2018 - 01/2014
3	Palindromic rheumatism 12/2021 - 08/2014
2	Arthritis (Polyarthritis) 12/2021 - 01/2014
2	Synovitis 01/2016 - 08/2014
1	Pain (Aches) 04/2022
1	Pericarditis 12/2021
1	Abdominal Pain (Pain, Abdominal) 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Fever (Fevers) 12/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021
1	Inflammation (Inflammations) 07/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2018
1	Edema (Dropsy) 12/2017
1	Joint Diseases (Joint Disease) 01/2016
1	Necrosis 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Ankylosing Spondylitis 01/2014

Drug/Important Bio-Agent (IBA)

5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2018 - 12/2015
4	baricitinibIBA 08/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 12/2017
3	Adalimumab (Humira)FDA Link 01/2019 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2014
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2016 - 12/2015
2	AntibodiesIBA 12/2021 - 01/2017
2	Tumor Necrosis Factor InhibitorsIBA 12/2018 - 01/2016
2	Infliximab (Remicade)FDA Link 01/2016 - 01/2016
2	Etanercept (Enbrel)FDA Link 01/2016 - 01/2016
1	Janus KinasesIBA 04/2022
1	AutoantibodiesIBA 12/2021
1	Rheumatoid FactorIBA 12/2021
1	Colchicine FDA LinkGeneric 12/2021
1	SDMIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2019
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	EpitopesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	C-Reactive ProteinIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	tocilizumab (atlizumab)FDA Link 12/2015
1	Biological ProductsIBA 01/2014

Therapy/Procedure

3	Therapeutics 09/2021 - 01/2017
2	Drug Tapering 12/2019 - 01/2014
1	Aftercare (After-Treatment) 04/2022
1	Biological Therapy 01/2014